Hematology/Oncology

Top Story

Stereotactic ablative radiotherapy confers clinical benefit in oligometastatic prostate cancer

Stereotactic ablative radiotherapy confers clinical benefit in oligometastatic prostate cancer
April 6, 2020
FDA News

FDA approves Reblozyl to treat anemia among adults with lower-risk myelodysplastic syndrome

April 6, 2020
The FDA approved luspatercept-aamt to treat anemia among certain adults with lower-risk myelodysplastic syndrome. The approval is the first in more than a decade for…
In the Journals

Fiber consumption linked to lower breast cancer risk

April 6, 2020
High fiber consumption appeared to be associated with reduced risk for breast cancer, according to results of a meta-analysis of prospective observational studies…

Global Blood Therapeutics commits $250,000 to support sickle cell disease community amid COVID-19

April 6, 2020
Global Blood Therapeutics committed $250,000 to support the sickle cell disease community during the COVID-19 pandemic. The company’s newly established its GBT…

Parker Institute for Cancer Immunotherapy awards grants to six early career researchers

April 5, 2020
Parker Institute for Cancer Immunotherapy awarded up to $2.75 million in grant funding to six early career researchers. In addition to financial support, the…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next